Works by Bairey, Osnat

Results: 56

<sup>18</sup>F-FDG-PET/CT Pulmonary Infiltrates in non-Hodgkin's lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.

Published in:

Israel Medical Association Journal, 2017, v. 19, n. 6, p. 372

By:

Cohen, Yael C.;
Berger, Tamar;
Eshel, Lora;
Stern, Dorit;
Bairey, Osnat;
Raanani, Pia;
Shpilberg, Ofer

Publication type:

Article

Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35).

Published in:

Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3312

By:

Pirosa, Maria Cristina;
Steffanoni, Sara;
Vanazzi, Anna;
Esposito, Fabiana;
Polino, Angela;
Schena, Alberto;
Landi, Francesco;
Cabrera, Maria Elena;
Akhtar, Saad;
Gardella, Santiago;
Bairey, Osnat;
Pavlovsky, Astrid;
Stathis, Anastasios;
Zucca, Emanuele

Publication type:

Article

A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma—Outcomes indicative for improved survival overtime.

Published in:

Hematological Oncology, 2023, v. 41, n. 5, p. 838, doi. 10.1002/hon.3198

By:

Bairey, Osnat;
Lebel, Eyal;
Buxbaum, Chen;
Porges, Tzvika;
Taliansky, Alisa;
Gurion, Ronit;
Goldschmidt, Neta;
Shina, Tzahala Tzuk;
Zektser, Miri;
Hofstetter, Liron;
Siegal, Tali

Publication type:

Article

Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.

Published in:

2019

By:

Herishanu, Yair;
Tadmor, Tamar;
Braester, Andrei;
Bairey, Osnat;
Aviv, Ariel;
Rahimi‐Levene, Naomi;
Fineman, Riva;
Levi, Itai;
Yuklea, Mona;
Ruchlemer, Rosa;
Shvidel, Lev;
Polliack, Aaron;
Rahimi-Levene, Naomi

Publication type:

journal article

Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.

Published in:

2018

By:

Joffe, Erel;
Ariela Arad, N.;
Bairey, Osnat;
Fineman, Riva;
Ruchlemer, Rosa;
Rahimi‐Levene, Naomi;
Shvidel, Lev;
Greenbaum, Uri;
Aviv, Ariel;
Tadmor, Tamar;
Braester, Andrei;
Goldschmidt, Neta;
Polliack, Aaron;
Herishanu, Yair;
Rahimi-Levene, Naomi

Publication type:

journal article

Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.

Published in:

2016

By:

Bairey, Osnat;
Shacham‐Abulafia, Adi;
Shpilberg, Ofer;
Gurion, Ronit

Publication type:

journal article

Conventional Dose Fludarabine-based Regimens are Effective but have Excessive Toxicity in Elderly Patients with Refractory Chronic Lymphocytic Leukemia.

Published in:

Leukemia & Lymphoma, 2003, v. 44, n. 11, p. 1947, doi. 10.1080/1042819031000110991

By:

Shvidel, Lev;
Shtalrid, Mordechai;
Bairey, Osnat;
Rahimi-Levene, Naomi;
Lugassy, Gilles;
Shpilberg, Ofer;
Polliack, Aaron;
Berrebi, Alain

Publication type:

Article

Serum CA 125 as a Prognostic Factor in Non-Hodgkin's Lymphoma.

Published in:

Leukemia & Lymphoma, 2003, v. 44, n. 10, p. 1733, doi. 10.1080/1042819031000104079

By:

Bairey, Osnat;
Blickstein, Dorit;
Stark, Pinhas;
Prokocimer, Miron;
Nativ, Hila Magem;
Kirgner, Ilia;
Shaklai, Mati

Publication type:

Article

Relapse of Aggressive Myeloma after Complete Remission in Secondary Acute Leukemia: Coincidence or Consequence??

Published in:

Leukemia & Lymphoma, 1993, v. 12, n. 1/2, p. 147, doi. 10.3109/10428199309059584

By:

Bairey, Osnat S.;
Shaklai, Matityahu;
Sandbank, Yehudith

Publication type:

Article

Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survival.

Published in:

Cancer (0008543X), 2015, v. 121, n. 17, p. 2909, doi. 10.1002/cncr.29487

By:

Bairey, Osnat;
Shvidel, Lev;
Perry, Chava;
Dann, Eldad J.;
Ruchlemer, Rosa;
Tadmor, Tamar;
Goldschmidt, Neta

Publication type:

Article

Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: A study of 176 patients with prognostic implications.

Published in:

2013

By:

Tadmor, Tamar;
Shvidel, Lev;
Aviv, Ariel;
Ruchlemer, Rosa;
Bairey, Osnat;
Yuklea, Mona;
Herishanu, Yair;
Braester, Andre;
Levene, Naomi;
Vernea, Fiona;
Ben-Ezra, Jonathan;
Bejar, Jacob;
Polliack, Aaron;
Israeli CLL Study Group

Publication type:

Journal Article

Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis.

Published in:

Cancer (0008543X), 2013, v. 119, n. 10, p. 1853, doi. 10.1002/cncr.27930

By:

Tadmor, Tamar;
Shvidel, Lev;
Aviv, Ariel;
Ruchlemer, Rosa;
Bairey, Osnat;
Yuklea, Mona;
Herishanu, Yair;
Braester, Andre;
Levene, Naomi;
Vernea, Fiona;
Ben‐Ezra, Jonathan;
Bejar, Jacob;
Polliack, Aaron

Publication type:

Article

The Utility of <sup>18</sup>F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.

Published in:

Israel Medical Association Journal, 2019, v. 21, n. 9, p. 580

By:

Feuerman, Hana;
Snast, Igor;
Amitay-Laish, Iris;
Bairey, Osnat;
Barzilai, Aviv;
Feinmesser, Maora;
Mimouni, Daniel;
Even-Sapir, Einat;
Hodak, Emmilia

Publication type:

Article

CLL-045: Long-Term Follow-up, Up to 7 Years, in the RESONATE-2 Study of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S316, doi. 10.1016/S2152-2650(21)01747-X

By:

Burger, Jan;
Barr, Paul;
Owen, Carolyn;
Robak, Tadeusz;
Tedeschi, Alessandra;
Bairey, Osnat;
Hillmen, Peter;
Coutre, Steve;
Devereux, Stephen;
Grosicki, Sebastian;
McCarthy, Helen;
Li, Jianyong;
Offner, Fritz;
Moreno, Carol;
Dai, Sandra;
Szoke, Anita;
Dean, James P.;
Kipps, Thomas J.;
Ghia, Paolo

Publication type:

Article

Poster: CLL-045: Long-Term Follow-up, Up to 7 Years, in the RESONATE-2 Study of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S221, doi. 10.1016/S2152-2650(21)01393-8

By:

Burger, Jan;
Barr, Paul;
Owen, Carolyn;
Robak, Tadeusz;
Tedeschi, Alessandra;
Bairey, Osnat;
Hillmen, Peter;
Coutre, Steve;
Devereux, Stephen;
Grosicki, Sebastian;
McCarthy, Helen;
Jianyong Li;
Offner, Fritz;
Moreno, Carol;
Dai, Sandra;
Szoke, Anita;
Dean, James P.;
Kipps, Thomas J.;
Ghia, Paolo

Publication type:

Article

Five-Year Follow-Up After Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S274, doi. 10.1016/j.clml.2019.07.205

By:

Burger, Jan;
Tedeschi, Alessandra;
Barr, Paul M.;
Robak, Tadeusz;
Owen, Carolyn;
Ghia, Paolo;
Bairey, Osnat;
Hillmen, Peter;
Coutre, Steven E.;
Devereux, Stephen;
Grosicki, Sebastian;
McCarthy, Helen;
Li, Jianyong;
Simpson, David;
Offner, Fritz;
Moreno, Carol;
Dai, Sandra;
Lal, Indu;
Dean, James P.;
Kipps, Thomas J.

Publication type:

Article

Phase 3 Study of Ibrutinib versus Chlorambucil in Patients ≥65 Years with Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S45, doi. 10.1016/j.clml.2016.07.065

By:

Burger, Jan;
Tedeschi, Alessandra;
Barr, Paul;
Robak, Tadeusz;
Owen, Carolyn;
Ghia, Paolo;
Bairey, Osnat;
Hillmen, Peter;
Bartlett, Nancy;
Li, Jianyong;
Simpson, David;
Grosicki, Sebastian;
Devereux, Stephen;
McCarthy, Helen;
Coutre, Steven;
Quach, Hang;
Gaidano, Gianluca;
Maslyak, Zvenyslava;
Stevens, Don;
Janssens, Ann

Publication type:

Article

Analysis of Quality of Life and Well-being from the Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Older Patients with Treatment-naïve CLL (RESONATE-2TM).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S46, doi. 10.1016/j.clml.2016.07.066

By:

Kipps, Thomas;
Ghia, Paolo;
Tedeschi, Alessandra;
Barr, Paul;
Robak, Tadeusz;
Owen, Carolyn;
Bairey, Osnat;
Hillmen, Peter;
Bartlett, Nancy;
Li, Jianyong;
Simpson, David;
Grosicki, Sebastian;
Deverux, Stephen;
McCarthy, Helen;
Coutre, Steven;
Offner, Fritz;
Moreno, Carol;
Zhou, Cathy;
Styles, Lori;
James, Danelle

Publication type:

Article

Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.

Published in:

European Journal of Haematology, 2007, v. 79, n. 3, p. 205, doi. 10.1111/j.1600-0609.2007.00895.x

By:

Perry, Chava;
Herishanu, Yair;
Metzer, Ur;
Bairey, Osnat;
Ruchlemer, Rosa;
Trejo, Leonor;
Naparstek, Elizabeth;
Sapir, Einat Even;
Polliack, Aaron

Publication type:

Article

Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.

Published in:

European Journal of Haematology, 2006, v. 76, n. 5, p. 384, doi. 10.1111/j.1600-0609.2005.00620.x

By:

Bairey, Osnat;
Blickstein, Dorit;
Monselise, Yehudit;
Lahav, Judith;
Stark, Pinhas;
Prokocimer, Miron;
Nativ, Hila Magen;
Kirgner, Ilia;
Pazgal, Idit;
Shaklai, Mati

Publication type:

Article

Limited Positron Emission Tomography-Computed Tomography for Restaging of Lymphoma: A Strategy for Reducing Radiation Exposure among Patients with Early-Stage Curable Lymphoma.

Published in:

Acta Haematologica, 2014, v. 131, n. 4, p. 239, doi. 10.1159/000354842

By:

Wolach, Ofir;
Bernstine, Hanna;
Edel, Yonatan;
Bairey, Osnat;
Shpilberg, Ofer;
Groshar, David;
Lahav, Meir

Publication type:

Article

Is Bone Marrow Biopsy Obligatory in All Patients with Non-Hodgkin’s Lymphoma?

Published in:

Acta Haematologica, 2007, v. 118, n. 1, p. 61, doi. 10.1159/000102589

By:

Bairey, Osnat;
Shpilberg, Ofer

Publication type:

Article

A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

Published in:

Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985

By:

Bairey, Osnat;
Taliansky, Alisa;
Glik, Amir;
Amiel, Alexandra;
Yust‐Katz, Shlomit;
Gurion, Ronit;
Zektser, Miri;
Porges, Tzvika;
Sarid, Nadav;
Horowitz, Netanel A.;
Shina, Tzahala Tzuk;
Lebel, Eyal;
Cohen, Amos;
Geiger, Karyn Revital;
Raanani, Pia;
Wolach, Ofir;
Siegal, Tali

Publication type:

Article

Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.

Published in:

Annals of Hematology, 2013, v. 92, n. 5, p. 661, doi. 10.1007/s00277-012-1663-3

By:

Shvidel, Lev;
Tadmor, Tamar;
Braester, Andrei;
Bairey, Osnat;
Rahimi-Levene, Naomi;
Herishanu, Yair;
Klepfish, Abraham;
Shtalrid, Mordechai;
Berrebi, Alain;
Polliack, Aaron

Publication type:

Article

Early death in patients diagnosed with non-Hodgkin's lymphoma.

Published in:

Annals of Hematology, 2013, v. 92, n. 3, p. 345, doi. 10.1007/s00277-012-1623-y

By:

Bairey, Osnat;
Bar-Natan, Michal;
Shpilberg, Ofer

Publication type:

Article

Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients.

Published in:

Annals of Hematology, 2012, v. 91, n. 10, p. 1597, doi. 10.1007/s00277-012-1492-4

By:

Shvidel, Lev;
Braester, Andrei;
Bairey, Osnat;
Rahimi-Levene, Naomi;
Herishanu, Yair;
Tadmor, Tamar;
Klepfish, Abraham;
Ruchlemer, Rosa;
Shtalrid, Mordechai;
Berrebi, Alain;
Polliack, Aaron

Publication type:

Article

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.

Published in:

Annals of Hematology, 2011, v. 90, n. 10, p. 1123, doi. 10.1007/s00277-011-1259-3

By:

Bairey, Osnat;
Ruchlemer, Rosa;
Rahimi-Levene, Neomy;
Herishanu, Yair;
Braester, Andre;
Berrebi, Alain;
Polliack, Aaron;
Klepfish, Avraham;
Shvidel, Lev

Publication type:

Article

Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.

Published in:

1997

By:

Bairey, Osnat;
Gabbay, Uri;
Blickstein, Dorit;
Stark, Pinhas;
Prokocimer, Miron;
Epstein, Orit;
Shaklai, Mati;
Lahav, Judith;
Bairey, O;
Gabbay, U;
Blickstein, D;
Stark, P;
Prokocimer, M;
Epstein, O;
Shaklai, M;
Lahav, J

Publication type:

journal article

Role and Prognostic Significance of the Ki-67 Index in Non-Hodgkin's Lymphoma.

Published in:

European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1

By:

Bairey, Osnat

Publication type:

Article

Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.

Published in:

Cancer (0008543X), 1996, v. 77, n. 11, p. 2313, doi. 10.1002/(SICI)1097-0142(19960601)77:11<2313::AID-CNCR20>3.0.CO;2-Z

By:

Shaklai, Sharon;
Bairey, Osnat;
Blickstein, Dorit;
Prokocimer, Miron;
Hadar, Herzlia;
Lahav, Meir;
Sulkes, Jaqueline;
Shaklai, Mati

Publication type:

Article

An evaluation of lateral and medial transposition of the ovaries out of radiation fields.

Published in:

1994

By:

Hadar, Herzlia;
Loven, David;
Herskovitz, Pearl;
Bairey, Osnat;
Yagoda, Arieh;
Levavi, Hanoch;
Hadar, H;
Loven, D;
Herskovitz, P;
Bairey, O;
Yagoda, A;
Levavi, H

Publication type:

journal article

Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma.

Published in:

1994

By:

Bairey, Osnat;
Kremer, Israel;
Rakowsky, Erica;
Hadar, Herzelia;
Shaklai, Mati;
Bairey, O;
Kremer, I;
Rakowsky, E;
Hadar, H;
Shaklai, M

Publication type:

journal article

The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants.

Published in:

British Journal of Haematology, 2020, v. 189, n. 2, p. e31, doi. 10.1111/bjh.16422

By:

Raz, Michal Ariela;
Arnason, Jon;
Bairey, Osnat;
Shvidel, Lev;
Aviv, Ariel;
Ben Baruch, Sharon;
Perry, Chava;
Sarid, Nadav;
Kirgner, Ilya;
Dvid, Varon;
Herishanu, Yair;
Avivi, Irit

Publication type:

Article

Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.

Published in:

British Journal of Haematology, 2017, v. 178, n. 5, p. 709, doi. 10.1111/bjh.14734

By:

Dann, Eldad J.;
Bairey, Osnat;
Bar‐Shalom, Rachel;
Mashiach, Tanya;
Barzilai, Elinor;
Kornberg, Abraham;
Akria, Luiza;
Tadmor, Tamar;
Filanovsky, Kalman;
Abadi, Uri;
Kagna, Olga;
Ruchlemer, Rosa;
Abdah‐Bortnyak, Roxolyana;
Goldschmidt, Neta;
Epelbaum, Ron;
Horowitz, Netanel A.;
Lavie, David;
Ben‐Yehuda, Dina;
Shpilberg, Ofer;
Paltiel, Ora

Publication type:

Article

The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma.

Published in:

British Journal of Haematology, 2008, v. 143, n. 2, p. 253, doi. 10.1111/j.1365-2141.2008.07338.x

By:

Ferreri, Andrés J. M.;
Dognini, Giuseppina P.;
Bairey, Osnat;
Szomor, Arpad;
Montalbán, Carlos;
Horvath, Barbara;
Demeter, Judit;
Uziel, Lilj;
Soffietti, Riccardo;
Seymour, John F.;
Ambrosetti, Achille;
Willemze, Rein;
Martelli, Maurizio;
Rossi, Giuseppe;
Candoni, Anna;
De Renzo, Amalia;
Doglioni, Claudio;
Zucca, Emanuele;
Cavalli, Franco;
Ponzoni, Maurilio

Publication type:

Article

Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment.

Published in:

European Journal of Haematology, 2018, v. 101, n. 5, p. 703, doi. 10.1111/ejh.13149

By:

Gentile, Massimo;
Shanafelt, Tait D.;
Mauro, Francesca Romana;
Reda, Gianluigi;
Rossi, Davide;
Laurenti, Luca;
Del Principe, Maria Ilaria;
Cutrona, Giovanna;
Angeletti, Ilaria;
Coscia, Marta;
Herishanu, Yair;
Chiarenza, Annalisa;
Molica, Stefano;
Ciolli, Stefania;
Goldschmidt, Neta;
Angrilli, Francesco;
Giordano, Annamaria;
Rago, Angela;
Bairey, Osnat;
Tripepi, Giovanni

Publication type:

Article

Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.

Published in:

European Journal of Haematology, 2018, v. 101, n. 3, p. 399, doi. 10.1111/ejh.13129

By:

Joffe, Erel;
Goldschmidt, Neta;
Bairey, Osnat;
Fineman, Riva;
Ruchlemer, Rosa;
Rahimi‐Levene, Naomi;
Shvidel, Lev;
Greenbaum, Uri;
Aviv, Ariel;
Tadmor, Tamar;
Braester, Andrea;
Arad, Ariela;
Polliack, Aaron;
Herishanu, Yair;
The Israeli CLL Study Group

Publication type:

Article

Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group.

Published in:

European Journal of Haematology, 2014, v. 93, n. 1, p. 29, doi. 10.1111/ejh.12290

By:

Shvidel, Lev;
Tadmor, Tamar;
Braester, Andrei;
Bairey, Osnat;
Rahimi‐Levene, Naomi;
Herishanu, Yair;
Klepfish, Abraham;
Ruchlemer, Rosa;
Berrebi, Alain;
Polliack, Aaron

Publication type:

Article

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group.

Published in:

European Journal of Haematology, 2012, v. 89, n. 6, p. 491, doi. 10.1111/ejh.12015

By:

Bairey, Osnat;
Goldschmidt, Neta;
Ruchlemer, Rosa;
Tadmor, Tamar;
Rahimi-Levene, Neomi;
Yuklea, Mona;
Shvidel, Lev;
Berrebi, Alain;
Polliack, Aaron;
Herishanu, Yair

Publication type:

Article

Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?

Published in:

Acta Haematologica, 2021, v. 144, n. 4, p. 389, doi. 10.1159/000511208

By:

Bairey, Osnat;
Shargian-Alon, Liat;
Siegal, Tali

Publication type:

Article

Primary CNS Lymphoma in the Elderly: The Challenge.

Published in:

Acta Haematologica, 2019, v. 141, n. 4, p. 138, doi. 10.1159/000495284

By:

Siegal, Tali;
Bairey, Osnat

Publication type:

Article

Primary CNS Lymphoma in the Elderly: The Challenge.

Published in:

Acta Haematologica, 2019, v. 141, n. 3, p. 138, doi. 10.1159/000495284

By:

Siegal, Tali;
Bairey, Osnat

Publication type:

Article

Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity.

Published in:

International Journal of Oncology, 2020, v. 57, n. 4, p. 1013

By:

Jubran, Ritta;
Saar-Ray, Moran;
Wawruszak, Anna;
Ziporen, Lea;
Donin, Natalie;
Bairey, Osnat;
Fishelson, Zvi

Publication type:

Article

Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study.

Published in:

American Journal of Hematology, 2023, v. 98, n. 2, p. E24, doi. 10.1002/ajh.26779

By:

Levi, Shai;
Bronstein, Yotam;
Goldschmidt, Neta;
Morabito, Fortunato;
Ziv‐Baran, Tomer;
Del Poeta, Giovanni;
Bairey, Osnat;
Del Principe, Maria Ilaria;
Fineman, Riva;
Mauro, Francesca Romana;
Gutwein, Odit;
Reda, Gianluigi;
Ruchlemer, Rosa;
Sportoletti, Paolo;
Laurenti, Luca;
Shvidel, Lev;
Coscia, Marta;
Tadmor, Tamar;
Varettoni, Marzia;
Aviv, Ariel

Publication type:

Article

Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection.

Published in:

Pharmaceutics, 2020, v. 12, n. 6, p. 520, doi. 10.3390/pharmaceutics12060520

By:

Kon, Edo;
Hazan-Halevy, Inbal;
Rosenblum, Daniel;
Cohen, Niv;
Chatterjee, Sushmita;
Veiga, Nuphar;
Raanani, Pia;
Bairey, Osnat;
Benjamini, Ohad;
Nagler, Arnon;
Peer, Dan

Publication type:

Article

Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.

Published in:

American Journal of Hematology, 2020, v. 95, n. 6, p. 604, doi. 10.1002/ajh.25766

By:

Herishanu, Yair;
Shaulov, Adir;
Fineman, Riva;
Bašić‐Kinda, Sandra;
Aviv, Ariel;
Wasik‐Szczepanek, Ewa;
Jaksic, Ozren;
Zdrenghea, Mihnea;
Greenbaum, Uri;
Mandac, Inga;
Simkovic, Martin;
Morawska, Marta;
Benjamini, Ohad;
Spacek, Martin;
Nemets, Anatoly;
Bairey, Osnat;
Trentin, Livio;
Ruchlemer, Rosa;
Laurenti, Luca;
Stanca Ciocan, Oana

Publication type:

Article

Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.

Published in:

American Journal of Hematology, 2019, v. 94, n. 9, p. 992, doi. 10.1002/ajh.25558

By:

Perry, Chava;
Ben Barouch, Sharon;
Goldschmidt, Neta;
Sarid, Nadav;
Yair Herishanu;
Shvidel, Lev;
Bairey, Osnat;
Lavi, Noa;
Horowitz, Netanel;
Avigdor, Avraham;
Lebel, Eyal;
Sofer, Orit;
Ram, Ron;
Avivi, Irit

Publication type:

Article

Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies.

Published in:

American Journal of Hematology, 2018, v. 93, n. 11, p. 1402, doi. 10.1002/ajh.25259

By:

Robak, Tadeusz;
Burger, Jan A.;
Tedeschi, Alessandra;
Barr, Paul M.;
Owen, Carolyn;
Bairey, Osnat;
Hillmen, Peter;
Simpson, David;
Grosicki, Sebastian;
Devereux, Stephen;
McCarthy, Helen;
Coutre, Steven E.;
Quach, Hang;
Gaidano, Gianluca;
Maslyak, Zvenyslava;
Stevens, Don A.;
Moreno, Carol;
Gill, Devinder S.;
Flinn, Ian W.;
Gribben, John G.

Publication type:

Article

Richter's transformation to diffuse large B-cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.

Published in:

American Journal of Hematology, 2014, v. 89, n. 11, p. E218, doi. 10.1002/ajh.23826

By:

Tadmor, Tamar;
Shvidel, Lev;
Bairey, Osnat;
Goldschmidt, Neta;
Ruchlemer, Rosa;
Fineman, Riva;
Rahimi-Levene, Naomi;
Herishanu, Yair;
Yuklea, Mona;
Arad, Ariela;
Aviv, Ariel;
Polliack, Aaron

Publication type:

Article

Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel.

Published in:

American Journal of Hematology, 2011, v. 86, n. 12, p. 985, doi. 10.1002/ajh.22160

By:

Shvidel, Lev;
Braester, Andrei;
Bairey, Osnat;
Rahimi-Levene, Naomi;
Klepfish, Abraham;
Herishanu, Yair;
Shtalrid, Mordechai;
Polliack, Aaron;
Berrebi, Alain

Publication type:

Article